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Abstract
Rationale: We have previously shown increased cardiac stanniocalcin-1 (STC1) in patients with idiopathic dilated
cardiomyopathy. STC1 localizes to the inner mitochondrial membrane and transgenic over-expression of STC1 is associated
with increased energy utilization.
Objective: We examined the hypothesis that STC1 uncouples mitochondrial oxidative phosphorylation - to suppress
superoxide generation and modulate neurohormonal effects on cardiomyocytes.
Methods and Results: Compared to WT mouse heart, STC1 Tg heart displays: 2-fold higher uncoupling protein 3 (UCP3)
levels, but no effect on UCP2 protein; 40% lower ATP levels; but similar activities of respiratory chain complexes I-IV. In
cultured adult rat and freshly-isolated mouse cardiomyocytes, rSTC1 induces UCP3, but not UCP2. Treatment of
cardiomyocytes with STC1 decreases mitochondrial membrane potential and suppresses baseline and angiotensin II (Ang
II)-induced superoxide generation. Furthermore, baseline superoxide generation is higher in freshly-isolated adult UCP3
2/2
mouse cardiomyocytes compared to WT, suggesting an important role for UCP3 in regulating cardiomyocyte ROS under
physiologic conditions. Treatment of UCP3
2/2 cardiomyocytes with rSTC1 failed to suppress superoxide generation,
suggesting that the effects of STC1 on superoxide generation in cardiomyocytes are UCP3-dependent.
Conclusion: STC1 activates a novel anti-oxidant pathway in cardiac myocytes through induction of UCP3, and may play an
important role in suppressing ROS in the heart under normal physiologic conditions and ameliorate the deleterious effects
of Ang II-mediated cardiac injury. Importantly, our data point to a critical role for the mitochondria in regulating ROS
generation in response to Ang II.
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Introduction
Previous data from our laboratory demonstrated upregulation
of the mammalian homologue of fish STC1 in the hearts of
patients suffering from idiopathic dilated cardiomyopathy (DCM)
[1]. However, the physiologic/pathophysiologic significance of
STC1 upregulation in DCM remains to be elucidated. Mamma-
lian STC1 is expressed in many tissues and organs including the
heart and skeletal muscle [2] and is defined as an intracrine
protein; i.e., an intracellular-acting, extracellular signaling protein
[3]. STC1 is released to the extracellular milieu [4] followed by
binding to a cell-surface protein [5], internalization into the cell
and targeting to the mitochondria [6,7]; however, the mechanism
of internalization and targeting remains unclear. Moreover, recent
reports suggest that mammalian STC1 is blood borne [8,9] –
attached to a soluble protein [8], and thus, may also function as a
circulating hormone.
Data from McCudden et al. [6] suggested the involvement of
STC1 in cellular energy metabolism. Electron microscopy and
immunofluorescence studies localized STC1 to the mitochondria
[6,10] and studies in bovine heart mitoplasts suggested that STC1
enhances NADH disappearance [6]; while treatment of isolated
mitochondria with STC1 uncoupled phosphorylation [11].
Of interest, STC1 Tg mice are hyperphagic and hypermet-
abolic [12,13] and display nearly identical phenotype to UCP3
Tg mice [14]. UCP3 is a homologue of UCP1, which is
abundantly expressed in mitochondria of brown adipocytes,
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regulation] [15]. On the other hand, UCP1 homologues are
expressed at low abundance in other tissues and organs [UCP2
in lymphoid cells [16]; UCP3 in the heart and skeletal muscle
[17,18]; UCP4 and UCP5 in the brain [19]] and appear to play
an important role in decreasing mitochondrial superoxide
generation at the expense of slight reduction in the efficiency
of ATP generation [19–21]. Therefore, we hypothesized that
STC1 induces mitochondrial uncoupling proteins in cardiomy-
ocytes to reduce superoxide generation. Our data confirm this
hypothesis and suggest the existence of a novel STC1-induced
and UCP3-mediated pathway to suppress baseline and Ang II-
induced superoxide generation in cardiomyocytes and point to a
critical role for the mitochondria in regulating ROS generation
in response to Ang II.
Results
Upregulation of Cardiac UCP3 in STC1 Tg Mice
To determine whether the expression of cardiac STC1
correlates with the expression of UCP2 and UCP3, the
prevailing UCPs in the heart [18], we compared whole
ventricular or mitochondrial lysates from WT and STC1 Tg
mice and found higher level expression of UCP3 protein in
mitochondria of STC1 Tg mouse heart compared with WT
mice (Figures 1A and 1C), that correlated positively with
STC1 protein levels in ventricular tissue of STC1 Tg mice
(Figures 1B and 1D). Similarly, mRNAs for STC1 and UCP3
were higher in STC1 Tg hearts compared with WT hearts
(Figures 1E and 1F). Quantitatively, and relative to WT,
STC Tg hearts displayed 5-fold higher levels of both STC1
mRNA and protein; on the other hand UCP3 mRNA levels
were 6-fold higher, while UCP3 protein levels were only 2-fold
higher; or 1:1 correlation between STC1 mRNA and protein vs
3:1 for UCP3 mRNA and protein, respectively, suggesting that
while there is positive correlation between STC1 and UCP3,
both at the mRNA and protein level, the regulatory schemes for
these two genes differ. UCP2 protein levels were similar in
mitochondrial lysates of WT and STC1 Tg hearts (Figures 1A).
These data suggest a role for STC1 in the regulation of cardiac
UCP3 and hence, free radicals production in the heart.
Tg Overexpression of STC1 is Associated with Decreased
Cardiac ATP Content, but not the Activities of Respiratory
Chain Complexes I-IV
Increased expression of UCP3 in cardiac mitochondria is
expected to induce uncoupling of phosphorylation; consequently,
the efficiency of ATP generation should be lower. In the following
experiment, we determined ATP levels in the hearts of WT and
STC1 Tg mice. Our results revealed 40% lower ATP levels in
ventricular lysates of STC1 Tg mice (Figure 2). The data are
consistent with increased mitochondrial uncoupling in the heart of
STC1 Tg mice and suggest an important role for STC1 in cardiac
energy metabolism.
Since oxidative phosphorylation and the activities of mitochon-
drial respiratory chain complexes motivate cellular ATP produc-
tion, we examined the activities of respiratory chain complexes I-
IV in total heart lysates of WT and STC1 Tg mice. Our results
showed no differences in the activities of complex I, complex II,
complex I+II, complex II+III, or complex IV (Figure 3). These
data rule out inhibition of mitochondrial respiratory chain
complexes I-IV as the cause for the lower ATP levels we observe
in the hearts of STC1 Tg mice.
STC1 Induces UCP3 in Cardiomyocytes
Uncoupling proteins UCP2 and UCP3 play an important role
in regulating superoxide generation [20] and are expressed in the
heart [18]. In the following experiment, we sought to determine
the effect of rSTC1 protein on the expression of UCP2 and UCP3
in cultured primary adult rat cardiac myocytes and freshly-isolated
adult mouse cardiomyocytes. Of note, STC1 levels in human left
ventricular tissue obtained from patients with DCM at the time of
left ventricular assist device placement may exceed 200 ng/g wet
weights (unpublished observations). Treatment of cultured rat
cardiomyocytes with STC1 [100 ng/mL; based on dose response
curves (data not shown] increased the expression of UCP3
(Figure 4A), but had no effect on UCP2 protein expression (data
not shown). Similarly, treatment of freshly-isolated adult mouse
cardiac myocytes with rSTC1 increased the expression of UCP3
mRNA 5.4-fold (Figure 4C), and protein 2-fold (Figure 4B), but
had no effect on the expression of UCP2 protein (Figure 4D).
Upregulation of uncoupling proteins is expected to shunt
protons from the mitochondrial inter-membrane space to the
matrix and diminish mitochondrial membrane potential (depolar-
ization). Treatment of cardiac myocytes with rSTC1 (100 ng/mL)
for 5 h decreased membrane potential 38% (Figure 5A), mea-
sured as JC-1 fluorescence. Our data are consistent with STC1-
induced and UCP3-mediated mitochondrial uncoupling, and
predict attenuation of superoxide generation.
Transient uncoupling of mitochondrial oxidative phosphoryla-
tion using pharmacologic uncouplers results in depolarization of
mitochondrial membrane potential, diminishing ROS generation
[22–24]. Hence we examined the effect of rSTC1 (100 ng/mL) on
superoxide generation in cultured adult rat cardiac myocytes
(measured semi quantitatively as ethidium bromide fluorescence)
and determined the impact of STC1 on Ang II-mediated
superoxide generation. Of interest, rSTC1 diminishes baseline
and Ang II-mediated superoxide generation (Figure 5B and 5C),
suggesting a potential role for STC1 in regulating cardiac free
radicals under physiologic and pathophysiologic conditions.
In the following experiments, we sought to determine whether
the effects of STC1 on superoxide generation are mediated
through uncoupling proteins. Cardiomyocytes express 2 uncou-
pling proteins, UCP2 and UCP3 [18]. While UCP3 was induced
by STC1, UCP2 was not. Therefore, we carried out the next set of
experiments using freshly-isolated WT and UCP3
2/2 mouse
cardiomyocytes. In WT cardiomyocytes, STC1 diminishes base-
line and Ang II-induced superoxide generation (Figure 6),
validating our observations in cultured primary rat cardiomyocytes
shown in Figure 5. Of interest, baseline superoxide generation
was higher in UCP3
2/2 mouse cardiomyocytes, compared to WT
(Figure 6), and treatment of UCP3
2/2 cardiomyocytes with
STC1 failed to suppress baseline or ANG-II-induced superoxide
(Figure 6). These data suggest that UCP3 plays an important role
in suppressing free radicals in the heart under physiologic
conditions, and that suppression of superoxide generation by
STC1 is UCP3-mediated. More importantly, our data suggest that
suppression of Ang II-mediated superoxide generation by STC1
requires UCP3, pointing to a critical role for the mitochondria in
regulating ROS generation in response to Ang II. Collectively, our
data suggest the existence of a novel STC1-induced and UCP3-
mediated pathway to suppress baseline and Ang II-induced
superoxide generation in cardiomyocytes.
Discussion
The function of mammalian STC1 is not fully defined. Previous
data from our lab suggested a role for STC1 in cardiac function, as
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and blood vessels of failing human heart secondary to DCM [1];
whereas, following treatment with left ventricular assist device,
STC1 expression is ‘‘normalized’’ [1], suggesting regulation of
STC1 by modifiable factors related to ventricular load. However,
it was unclear what role STC1 plays in DCM. Several lines of
evidence implicate ROS in the development and progression of
heart failure (reviewed in [25]): first, the levels of ROS are elevated
in both plasma and myocardial tissue in heart failure; second,
hypertrophy and apoptosis of cardiac cells in response to
neurohormones such as norepinephrine, ANG-II, or cytokines
appear to be modulated by redox-sensitive pathways, as the
administration of scavengers of ROS diminishes cardiac remod-
eling after myocardial infarction, a condition characterized by
increased generation of ROS. Mitochondrial electron transport
chain and non-phagocytic NADPH oxidases are the predominant
sources of ROS in cardiomyocytes [26,27]; however little is known
about the contribution and regulation of specific sources of ROS
in response to neurohormones.
Heart failure is associated with activation of the renin-
angiotensin-system and it is well-established that ANG-II induces
cardiac injury partially through increased generation of ROS
Figure 1. The expression of STC1 positively correlates with UCP3, but not UCP2 in the heart; rSTC1 induces UCP3, but not UCP2 in
freshly-isolated mouse cardiac myocytes. I. Increased expression of UCP3, but not UCP2 protein in cardiac mitochondria of STC1 Tg
mice.ProteinlysatesrepresentingventricularmitochondriallysatesfromWTandSTC1Tgmicewereresolvedon12%SDS-PAGE,andblotswerereacted
with anti-UCP3, anti-UCP2 and anti-mitochondrial F1-ATPase (as internal control). Inset (A) shows representative Western blots of UCP3, UCP2 and the
mitochondrialF1-ATPase.Bargraph(C)depictsUCP3proteinlevelsinheartmitochondriallysatesofWTandSTC1Tgmice,normalizedtoF1-ATPaseprotein
levels, and presented as arbitrary density units; data represent the mean 6 SEM of 4–6 independent determinations from each group. II. HigherSTC1
proteinlevelsinventricularlysatesofSTC1Tgmice:ProteinlysatesrepresentingventriculartissuefromWTandSTC1Tgmicewereresolvedon12%
SDS-PAGE,andblotswerereactedwithanti-STC1antibodyandanti-b-actinantibody;notethedisappearanceofSTC1band(s)inthepresenceofblocking
peptide,indicatingspecificityoftheantibody(B).Inset(B)showsrepresentativeWesternblotsofSTC1andb-actin.Bargraph(D)showsbandintensities
(correspondingtoB)normalizedtob-actinandpresentedasarbitrarydensityunits;datarepresentthemean6SEMof6independentdeterminations.III.
Correlation between STC1 and UCP3 mRNAs in the heart: Real-time PCR was carried out on total RNA isolated from WT and STC1 Tg hearts to
quantitateSTC1andUCP3mRNAsasdescribedinmethods.BargraphsdepictUCP3(E)andSTC1(F)mRNAlevelsnormalizedtob-actinmRNAleveland
presentedas arbitrarydensityunits;datarepresentthe mean6SEMof3–6 independentdeterminations.
doi:10.1371/journal.pone.0036994.g001
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proteins in the regulation of ROS in the heart and other organs.
Since STC1 is upregulated in the heart in patients suffering from
dilated cardiomyopathy, we reasoned that STC1 may play a role
in suppressing Ang II-mediated ROS. Hence, we examined the
effect of STC1 on Ang II-induced superoxide generation in
cultured adult rat cardiomyocytes and freshly-isolated adult
UCP3
2/2 mouse cardiac myocytes. We chose UCP32/2
cardiomyocytes because UCP3 is the predominant UCP in the
heart [18], was increased in STC1 Tg hearts and was induced by
STC1 in cultured rat cardiomyocytes and freshly-isolated mouse
cardiac myocytes, while UCP2 was not. Our data suggest that: A)
STC1 decreases baseline and Ang II-induced superoxide gener-
ation in cardiac myocytes; B) suppression of superoxide by STC1
is UCP3-dependent; C) knockout of cardiomyocyte UCP3 is
associated with increased baseline superoxide generation, suggest-
ing an important role for UCP3 in suppressing free radicals
production in the heart under normal physiologic conditions.
Finally, STC1 fails to suppress Ang II-mediated superoxide
generation in the absence of UCP3 expression.
The above data suggest that STC1 may have a protective role in
DCM, and may suppress ANG-II-mediated superoxide generation
in cardiomyocytes in vivo. STC1 action appears to require
mitochondrial UCP3 expression and importantly, our data point
to a critical role for the mitochondria in regulating ROS in
response to Ang II. It was traditionally thought that uncoupling of
the mitochondria increases the generation of ROS. However,
considerable recent evidence suggests otherwise. A group of UCP1
homologues has been discovered recently [UCP2 in the lymphoid
system; UCP3 in the heart and skeletal muscle [17,18]; UCP4 and
UCP5 in the brain [19]], and like pharmacologic uncouplers [24],
they diminish superoxide generation [19–21]. Therefore, in-
creased expression of UCP3 in cardiomyocytes is expected to
suppress the generation of ROS at the expense of slight reduction
in the efficiency of ATP generation (reviewed in [29]). In vivo, we
find positive correlation between the levels of STC1 and UCP3
protein in the heart. Consistently, ATP levels were lower in the
heart of STC1 Tg mice compared to WT mice. However, the
activities of respiratory chain complexes I-IV were similar. These
data suggest that the lower ATP levels we observe in the hearts of
STC1 Tg mice are related to mitochondrial uncoupling, rather
than to inhibition of respiratory chain.
The cellular and molecular mechanisms underlying DCM are
unclear. DCM may result from inherited defects in mitochondrial
energy metabolism; but, may also be associated with acquired
transcriptional dysregulation of metabolic enzymes [30–32], and
changes in mitochondrial oxidative phosphorylation [33]. Thus,
changes in mitochondrial structure/function may underlie DCM
and/or play a role in the adaptive/compensatory responses
initiated by the primary disease process. Low levels of ATP have
been reported to occur in the hearts of patients suffering from
DCM [34,35] and considering the higher levels of STC1 in the
hearts of DCM patients [1]. It is tempting to speculate that the
lower cardiac ATP levels observed in some of these patients may
result from STC1-driven and UCP3-mediated uncoupling of
mitochondrial phosphorylation. The ‘‘trade off’’, of course, is the
reduction in the generation of free radicals, which is expected to
provide cardio protection. While deletion of UCP3 increases ROS
[36], the long-term effects of UCP3 upregulation in the heart are
unknown. Knockout of UCP3 increases the efficiency of ATP
generation in skeletal muscle without affecting tricarboxylic acid
cycle flux rate [37], and it is reasonable to assume that increased
expression of UCP3 in the heart would predict reduction in the
efficiency of ATP generation and have deleterious effects on
cardiac function; however STC1 Tg mice display no overt cardiac
phenotype. Moreover, while STC1 inhibits L-type calcium
channels in cultured cardiomyocytes [1], an effect that may have
a negative impact on myocardial contractility and blood pressure,
particularly in the setting of heart failure [38], we observe normal
blood pressure in STC1 Tg mice, and unpublished observations
from our lab suggest that STC1 Tg mice outlive WT littermates.
In conclusion, our data suggest that STC1 may be an important
player in regulating ROS in the heart under normal physiologic
conditions and in the adaptive responses to pathophysiologic states
associated with DCM. Our data indicate that STC1 may also play
a critical role in ameliorating ANG-II-mediated oxidant injury and
point to a critical role for the mitochondria in regulating ROS
generation in response to Ang II.
Materials and Methods
Ethics Statement
The investigation conforms to the Guide for the Care and Use
of Laboratory Animals published by the US National Institutes of
Health (NIH Publication No. 85-23, revised 1996). Animal
experiments were approved by Institutional Animal Care and
Use Committee (IACUC).
Figure 2. Lower ATP levels in ventricular lysates of STC1 Tg
mice compared with WT. Total cellular ATP was extracted from
ventricular lysates of WT and STC1 Tg mice and measured using
luciferase assay. Values were calculated per gram tissue and presented
as % of controls. Data represent the mean 6 SEM of 3–6 independent
determinations.
doi:10.1371/journal.pone.0036994.g002
Figure 3. Transgenic overexpression of STC1 does not affect
the activities of respiratory chain complexes I-IV in ventricular
lysates. Ventricular lysates from WT and STC1 Tg mice were analyzed
for activities of respiratory chain complexes as described in methods.
Data represent the mean 6 SEM of 3–6 independent determinations.
Differences were not statistically significant.
doi:10.1371/journal.pone.0036994.g003
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All materials were purchased from Sigma (St Louis, MO) unless
stated otherwise. Recombinant hSTC1 protein was kindly
provided by Dr. Henrik Olsen, Human Genome Sciences
(Rockville, MD). It was produced using a baculovirus expression
system and is greater than 90% pure [39]. Endotoxin levels in
STC1 preparation were determined using Limulus Amebocyte
Lysate Test Kit (Cambrex Bio Science Walkersville, MD)
according to manufacturer’s instructions, and showed no detect-
able endotoxin. Goat anti-hSTC1 antibodies, immunizing peptide
for STC1, and goat anti-F1-ATPase were purchased from Santa-
Cruz (Santa Cruz, CA). Goat anti-UCP2 antibodies were
purchased from LifeSpan Bioscience Inc. (Seattle, WA). Rabbit
anti-UCP3 antibodies were purchased from Affinity Bioreagents
(Golden, CO).
Genetically-modified Mice
STC1 Tg mice were generated by Varghese et al. [12] and
made available for these studies. STC1 transgene expression is
driven by the metallothionein I minimal promoter and displays
preferential expression in the liver, brain, heart, and endothelial
cells [9,12]. Tg mice have normal blood pressure [9] and display
no overt cardiac phenotype. Serum calcium is normal, while
serum phosphate levels are slightly elevated [12]. Kidney function
and hematocrit are also normal (Kidney International, in press).
UCP3 null mice were a gift from Dr Edward Mills, University of
Texas, Austin, and have been described previously [40]. All studies
were carried out using 4–6 mo old mice homozygous for the
transgenes on C57BL/6 genetic background and the respective
WT mice generated from crosses between mice heterozygous for
the transgene.
Figure 4. STC1 induces UCP3, but not UCP2 protein in cultured adult rat and freshly-isolated adult mouse cardiac myocytes. A.
Cultured primary adult rat cardiac myocytes (7 days after suspension) were treated with rSTC1 protein (100 ng/mL) for 3 h, fixed in 4% saline buffered
paraformaldehyde, and stained for UCP3. B. Freshly-isolated adult mouse cardiac myocytes were treated with rSTC1 (100 ng/mL) for 3 h, harvested
by centrifugation and lysed in RIPA buffer or TRizol (for RNA preparation). Proteins were resolved on SDS-PAGE and Western blots were reacted with
anti-UCP3, anti-UCP2 or anti-b-actin antibodies as internal control, followed by standard detection using chemiluminescence. Real-time PCR was
carried out on total RNA to quantitate UCP3 mRNA as described in methods. Bar graphs in B and D depict band intensities for UCP3 and UCP2
proteins, respectively, normalized to b-actin and represent the mean 6 SEM of 5 independent determinations. Bar graph in C, depicts UCP3 mRNA,
normalized to b-actin mRNA and represent the mean 6 SEM of 3 independent determinations.
doi:10.1371/journal.pone.0036994.g004
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Adult rat cardiomyocytes were harvested as previously de-
scribed [41,42]. Briefly, following anesthesia (combination anes-
thetic contains/1 mL: ketamine 37.5 mg, xylazine 1.9 mg and
acepromazine 0.37 mg; given at 0.75–1.5 mL/kg body weight),
rats (4–6 mo old; average weight of 200 g) were given 3000 IU of
heparin by I.V. injection. The heart was exposed by a longitudinal
thoracotomy incision, and the thymus and fascia were cleared
from the aorta with a sterile swab. The aorta was cross-clamped
and cut distally, and the heart was removed and placed in 50 mL
of Joklik media [1 package of Joklik media powder (Gibco/
BRL), suspended in 50 mL water, and supplemented with 3.91 g
taurine, 2.0 g NaHCO3, 0.391 g L-glutamine and 0.282 g
adenosine]. The heart was rinsed and transferred to fresh ice-
cold Joklik media. The aorta was cannulated and flushed with cold
Joklik media using a syringe, followed by perfusion with a
perfusion pump at a rate of 12–15 mL/min, for 5 minutes. The
heart was then transferred to a Langendorff apparatus, flushed
with warm Joklik media, and digested by perfusion with Joklik
media containing 0.1% collagenase and 0.1% trypsin, for 45
minutes.
The ventricles were minced and placed in digestion buffer
containing 0.1% collagenase (in Joklik media). Minced heart tissue
was incubated in a shaking water bath at 37uC for 30 minutes.
The supernatant was transferred to a conical tube and centrifuged
(for 3 minutes, at 50 g). The resultant pellet was washed twice in
4% BSA solution and once in 2% BSA solution. The pellet was
then suspended in 20 mL Joklik media (pH 7.2), containing 2%
BSA, followed by slow addition of CaCl2 to yield a final
concentration of 1.25 mmol/L. The cells were finally recovered
by centrifugation (as above) and suspended by gentle pipetting in
4 mL of warm, serum-free DMEM.
The cell suspension (1–2 drops at a time) was then layered onto
sterile laminin-coated cover slips. After 30 minutes of incubation at
37uCi n5 %C O 2/95% O2 (to allow cell attachment) plating media
[DMEM containing 10% fetal bovine serum, 3 mg/mL cytarabine
(to inhibit fibroblast growth), 10 mg/mL insulin, and 5 U/mL
each of penicillin & streptomycin] was gently added. Cells were fed
with fresh plating media every other day. The cells began beating
after 5–7 days of incubation, and the experiments were carried out
between days 7–14.
Preparation of Freshly-isolated Mouse Cardiomyocytes
Mouse ventricular myocytes were isolated as described previ-
ously [43]. Briefly, the heart was removed following 1% isoflurane
anesthesia and rinsed in 0 Ca
2+ Tyrode solution (137 mmol/L
NaCl, 5.4 mmol/L KCl, 1 mmol/L MgCl2, 5 mmol/L HEPES,
10 mmol/L glucose, 3 mmol/L NaOH, pH 7.4). The heart was
cannulated through the aorta and perfused on a Langendorff
apparatus with 0 Ca
2+ Tyrode (3 , 5 minutes, 37uC), then 0 Ca
2+
Tyrode containing 20 mg/mL Liberase TH Research Grade
(0.104 a.u./mL; Roche Applied Science) for 10 , 15 minutes at
37uC. After digestion, the heart was perfused with 5 mL KB
solution (90 mmol/L KCl, 30 mmol/L K2HPO4, 5 mmol/L
MgSO4, 5 mmol/L pyruvic acid, 5 mmol/L b-hydroxybutyric
acid, 5 mmol/L creatine, 20 mmol/L taurine, 10 mmol/L
glucose, 0.5 mmol/L EGTA, 5 mmol/L HEPES, pH 7.2) to
wash out collagenase. The left ventricle of the heart was minced in
KB solution and gently agitated, then filtered through 210 mm
polyethylene mesh. After settling, ventricular myocytes were
washed once with KB solution, and then stored in KB solution
at room temperature before use.
Figure 5. STC1 attenuates mitochondrial membrane potential and diminishes baseline and Ang II-mediated superoxide generation
in cardiac myocytes. A. Freshly-isolated adult rat cardiac myocytes were treated with rSTC1 protein (100 ng/mL) for 5 h then JC-1 florescence
based assay was carried out. Mitochondrial membrane potential (Red/Green fluorescence ratio) was measured, and data represent mean 6 SEM of
three independent experiments. B. Cultured primary adult rat cardiomyocytes (7 days after suspension), were treated for 3 h with PBS, rSTC1 (100 ng/
mL), Ang II (100 ng/mL), or Ang II + rSTC1 at the above concentrations. DHE was added to the cell culture during the last 15 min of incubation. After
wash with PBS, ethidium bromide fluorescence intensity was measured using fluorescence microscope employing the same settings for all
measurements. Representative fluorescence images acquired from cardiomyocytes, treated as above are shown. C. Bar graph depicts mean 6 SEM of
ethidium bromide fluorescence acquired from cardiomyocytes, treated as above (n=20–40).
doi:10.1371/journal.pone.0036994.g005
Stanniocalcin-1 Suppresses ROS in Cardiomyocytes
PLoS ONE | www.plosone.org 6 May 2012 | Volume 7 | Issue 5 | e36994Measurement of Mitochondrial Membrane Potential
Mitochondrial membrane potential was measured using 3,39-
tetraethylbenzimidazolylcarbo-cyanine iodide (JC-1), as per man-
ufacturer’s instructions (Molecular Probe, Eugene, OR). JC-1 is a
lipophilic, cationic dye that can selectively enter into mitochondria
and reversibly change color from green to red as the membrane
potential increases. In cells with high mitochondrial membrane
potential, JC-1 spontaneously forms complexes known as J-
aggregates emitting intense red fluorescence (at ,590 nm). On
the other hand, in cells with low membrane potential, JC-1
remains in the monomeric form, which emits only green
fluorescence (at ,530 nm). Freshly-isolated adult rat cardiac
myocytes were treated with rSTC1 protein or PBS for the
indicated times. After treatment, cells were incubated with
50 nmol/L JC-1 at 37uC for 30 min and washed (3X) with PBS
(contains 3.2 mmol/L Na2HPO4, 0.5 mmol/L KH2PO4,
1.3 mmol/L KCl, 135 mmol/L NaCl, pH 7.4). The red JC-1
fluorescence was measured at 530 nm excitation/590 nm emis-
sion, and the green JC-1 fluorescence was measured at 485 nm
excitation/530 nm emission using a fluorescence-activated fluo-
rescence reader (BMG Lab Technologies, Germany). After
subtraction of background values obtained from wells containing
JC-1 but devoid of cells, red/green fluorescence ratios were
calculated.
Semi Quantitative Measurement of Superoxide
Mitochondria have been reported to generate superoxide and
may release these radicals into the extra-mitochondrial space [44].
Cultured adult rat cardiac myocytes were treated for 3 h with
combinations of the following: STC1 (100 ng/mL; optimal
concentration for induction of UCP3); Ang II (100 ng/mL); or
vehicle (PBS). During the last 15 min of treatment, cells were
incubated with 10 mmol/L dihydroethidium (DHE). After wash
with ice-cold PBS, ethidium bromide fluorescence intensity from
individual cells was measured using fluorescence microscope
employing the same settings for all measurements. Fluorescence
data derived from 20–40 cells per treatment were used for analysis.
Isolation of Heart Mitochondria
Mitochondria were isolated from mouse heart using a trypsin
digestionprocedureaspreviouslydescribed[45].Briefly,ventricular
tissue was minced, washed, and suspended in 1 mL of isolation
medium [0.3 mol/L sucrose, 10 mmol/L HEPES (pH 7.2), and
0.2 mmol/L EDTA]. The tissue was subjected to mild trypsin
digestion(0.125 mg/mL)for15 minat4uC,followedbytheaddition
of 1 mL isolation medium (pH 7.4) containing 1 mg/mL BSA and
0.65 mg of trypsin inhibitor. The partially digested tissue was
suspended in 1 mL of isolation medium containing 1 mg/mL
albumin and 1X complete protease inhibitor (Roche diagnostics,
Germany)andhomogenizedbrieflywithahighviscositymixer-glass
homogenizer (Henry Troemner LLC, USA). The homogenate was
centrifugedonabench-topcentrifugefor10 minat2000 rpm(4uC).
The supernatant was recovered and centrifuged for 15 min at
11000 rpm (4uC). The resulting pellet was washed twice in 1 mL of
isolation medium containing 1 mg/mL albumin and 1X complete
protease inhibitor. The pellet was recovered each time by centrifu-
gationat11000 rpmfor15 min(4uC).Thefinalpelletwassuspended
in0.1 mLofisolationmediumcontaining1 mg/mLalbuminand1X
completeproteaseinhibitor.ProteinwasdeterminedbytheBradford
assay usingBSA asa standard.
Measurement of Tissue ATP Level
Tissue ATP content was measured using the bioluminescent
somatic cell ATP assay kit (Sigma), as per manufacturer’s
instructions. Briefly, freshly harvested ventricular tissue from
WT or STC1 Tg mice was homogenized in somatic cellular ATP
releasing reagent, and cell lysates were incubated with ATP assay
mix. Cellular ATP levels were measured as bioluminescence using
a TD-20/20 luminometer (Turner Designs Instruments, Sunny-
vale, CA), and data were expressed as % of WT controls.
Mitochondrial Respiratory Chain Activity Assay
Ventriculartissuehomogenateswerepreparedat4uCusingTeflon
homogenizer,inabuffercontaining250 mmol/Lsucrose,2 mmol/
L EDTA and 100 mmol/L Tris-HCl, pH 7.4 [46]. The assay was
carriedoutonhomogenatesat30uCusingatemperature-controlled
spectrophotometer (Pharmacia, Biotech; Piscataway, NJ). The
activities of mitochondrial respiratory chain complex I (NADH
dehydrogenase),complexII(succinatedehydrogenase),complex
I + III (NADH:cytochrome c reductase), complex II + III
(succinate:cytochrome c reductase) and complex IV (cytochrome
coxidase)wereassayedusingdifferentelectronacceptors/donorsas
previously described [47,48]. NADH dehydrogenase activity was
measured as the rate of NADH oxidation (measurement of NADH
absorbance at 340 nm), using potassium ferric cyanide as the electron
acceptor.Succinatedehydrogenaseactivitywasmeasuredastherate
of 2,6-dichlorophenolindophenol (DCIP) reduction (measurement of
DCIPabsorbanceat600 nm),usingsuccinateaselectrondonor(reactionis
Figure 6. Suppression of superoxide generation by STC1 is
UCP3-dependent. Freshly-isolated adult cardiac myocytes from WT
and UCP3
2/2 mice were treated for 3 h with PBS, rSTC1 (100 ng/mL),
Ang II (1 mg/mL), or rSTC1+ Ang II at the same concentrations. DHE was
added to the medium during the last 15 min of incubation. After wash
with PBS, ethidium bromide fluorescence intensity was measured in
individual cells using fluorescence microscope employing the same
settings for all measurements. A. Bar graph depicts mean 6 SEM of
ethidium bromide fluorescence in vehicle-, Ang II-, rSTC1-, or rSTC1+
Ang II-treated cardiomyocytes (n=20–40). B. Western blot demon-
strates absence of UCP3 protein in heart mitochondrial lysates obtained
from UCP3
2/2 mice, compared to WT controls (4 independent
determinations). F1-ATPase was utilized as an internal control.
doi:10.1371/journal.pone.0036994.g006
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oxidase). NADH:cytochrome c reductase activities were measured as
therateofcytochromecreduction(measurementofcytochromecabsorbance
at 550 nm), using NADH as electron donor (reaction is carried out in the
presence of KCN – to inhibit cytochrome c oxidase). The activities of
succinate:cytochrome c reductase were measured as the rate of
cytochromecreduction(measurementofcytochromecabsorbanceat550 nm),
using succinate as electron donor (reaction is carried out in the presence of
KCN – to inhibit cytochrome c oxidase). Cytochrome c oxidase activity
(measurementofcytochromecabsorbanceat550 nm)wasmeasuredastherate
ofoxidationoffreshlyreducedcytochromec,usingNahydrosulfate.
To adjust enzymatic activities for mitochondrial content, the
activities were expressed as percentage of values in controls and
normalized to citrate synthase activity - measured as the reaction of
sodium oxaloacetate, acetyl-coenzyme A and 5,59-dithio-bis-(2
nitrobenzoic) acid at412 nm [48].
Western Blot Analysis
Heart mitochondrial preparations (to assay UCPs) or total heart
lysates (to assay STC1) from WT or STC1 Tg mice [12],
suspended in modified RIPA buffer [containing 150 mmol/L
NaCl, 50 mmol/L Tris-HCl (pH 7.4), 1% NP-40, 0.25% sodium
deoxycholate, 1 mmol/L EDTA, and 1X complete protease
inhibitor cocktail] were centrifuged at 8000 g for 10 min at 4uC
to remove cell debris. Fifteen mg of mitochondrial protein were
resolved on 12% SDS-PAGE, transferred to nitrocellulose
membrane and incubated with primary antibodies for UCP2,
UCP3 and F1-ATPase as internal controls. Similarly, 50 mgo f
protein lysate from freshly isolated mouse cardiomyocytes or
ventricular tissue were loaded per lane and Western blots reacted
with primary antibodies for UCP2, UCP3, STC1 or actin as
internal control. After washing with Tris buffered saline
[20 mmol/L Tris (pH 7.6), 137 mmol/L NaCl] containing 0.1%
Tween-20, the membrane was incubated with horse radish
peroxidase-conjugated secondary antibody, and the bound anti-
bodies were visualized using chemiluminescence.
RNA Isolation/Real-time PCR
Total RNAs was prepared from mouse heart tissues or mouse
cardiomyocytes using TRIzol reagent (Invitrogen, Grand Island,
NY) according to the manufacturer’s instructions. Total RNA was
treated with DNase I (Sigma, St. Louis, MO) prior to cDNA
production using cDNA synthesis Kit (Bio-Rad Laboratories,
Hercules, CA). Reaction conditions for cDNA synthesis were 25uC
for 5 min, 42uC for 30 min and 85uC for 5 min. Real-time PCR
was performed using Bio-Rad Real-Time PCR CFX 96 system.
Sequences for real-time PCR primers: STC1 forward primer (59-
CCATCACTGAAGTCATACA-39) and reverse primer (59-
TCATCACATTCCAGAAGG-39); UCP3 forward primer (59-
CTGTCATCGTCATCATCTA-39), and reverse primer (59-
GCTTTACCACTACAAACTG-39); b-actin forward primer (59-
ATCTTCCGCCTTAATACT -39), and reverse primer (59-
GCCTTCATACATCAAGTT -39). Twenty five nanograms of
total RNA were used for each PCR reaction with SYBR Green
(Bio-Rad Laboratories) detection at 10 ml reaction volumes. The
reaction conditions for PCR were (stage 1, Rep 1x) 95uC for 3 min,
(stage 2, Rep 1x) 95uC for 5 s, and (stage 3, Rep 39x) 60uC for 30 s
and then 60–95uC for 5 s. The relative mRNA expression levels
were calculated from cycle threshold (Ct) values using b-actin as
the endogenous control (relative expression=2
(target Ct2 reference Ct)).
Statistical Analysis
Data were expressed as the mean 6 SEM. Statistical
significance was determined by unpaired t test or ANOVA as
appropriate. A p value of ,0.05 was considered statistically
significant.
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